|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.385 USD | -1.77% |
|
+2.99% | - |
| Feb. 11 | Top Midday Gainers | MT |
| Feb. 10 | Neuronetics Reports Preliminary Fiscal Q4, 2025 Results | MT |
Company Valuation: Neuronetics, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 210.8 | 117.6 | 187 | 83.91 | 89.6 | 96.57 | 96.57 | - |
| Change | - | -44.22% | 59.02% | -55.13% | 6.79% | 7.77% | 0% | - |
| Enterprise Value (EV) | 210.8 | 117.6 | 187 | 83.91 | 89.6 | 96.57 | 96.57 | 96.57 |
| Change | - | -44.22% | 59.02% | -55.13% | 6.79% | 7.77% | 0% | 0% |
| P/E ratio | -7.61x | -3.66x | -4.98x | -2.76x | -1.18x | -2.38x | -3.07x | -4.32x |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | 0.2x | -0.4x | 0.1x | -0x | 0x | 0.1x | 0.1x |
| Capitalization / Revenue | 4.28x | 2.13x | 2.87x | 1.18x | 1.2x | 0.65x | 0.59x | 0.52x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 0.65x | 0.59x | 0.52x |
| EV / EBITDA | -0x | -0x | -0x | -0x | -0x | -4.62x | -8.55x | -11.8x |
| EV / EBIT | -0x | -0x | -0x | -0x | -0x | -3.04x | -3.99x | -5.13x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -1.46 | -1.22 | -1.38 | -1.05 | -1.37 | -0.5933 | -0.46 | -0.3267 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 49.24 | 55.31 | 65.21 | 71.35 | 74.5 | 148.3 | 164.2 | 184.3 |
| EBITDA 1 | -21.99 | -26.11 | -24.72 | -28.55 | -21.27 | -20.9 | -11.3 | -8.2 |
| EBIT 1 | -22.31 | -27.56 | -35.11 | -30.55 | -34.04 | -31.77 | -24.2 | -18.84 |
| Net income 1 | -27.45 | -31.19 | -37.16 | -30.19 | -43.2 | -39.29 | -32.4 | -24.14 |
| Net Debt | - | - | - | - | - | - | - | - |
| Reference price 2 | 11.110 | 4.460 | 6.870 | 2.900 | 1.610 | 1.410 | 1.410 | 1.410 |
| Nbr of stocks (in thousands) | 18,975 | 26,368 | 27,221 | 28,933 | 55,652 | 68,486 | 68,486 | - |
| Announcement Date | 3/2/21 | 3/8/22 | 3/7/23 | 3/5/24 | 3/4/25 | - | - | - |
1USD in Million2USD
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.38x | - | - | - | 96.57M | |
| 26.64x | 4.66x | 18.2x | 0.35% | 193B | |
| 56.22x | 14.57x | 33.89x | -.--% | 176B | |
| 31.56x | 5.97x | 18.68x | 0.65% | 143B | |
| 29.81x | 5.11x | 16.54x | -.--% | 108B | |
| 20.42x | 2.38x | 11.81x | 2.59% | 52.25B | |
| 29.11x | 6.62x | 21.29x | -.--% | 48.72B | |
| 24.12x | 6.4x | 16.43x | 0.95% | 37.19B | |
| 15.95x | 1.81x | 9.78x | 0.21% | 35.14B | |
| 22.66x | 4.65x | 16.09x | 0.87% | 33.38B | |
| Average | 25.41x | 5.80x | 18.08x | 0.63% | 82.71B | |
| Weighted average by Cap. | 33.23x | 6.99x | 20.67x | 0.45% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Equities
- STIM Stock
- Valuation Neuronetics, Inc.
Select your edition
All financial news and data tailored to specific country editions
